Mechanistically, SK activity promotes signaling through the Ras/Erk/Akt pathway [40,41,42,43,44,45,46,47,48,49] and regulates the sensitivities of tumor cells to anticancer drugs [50,51]. Here, AKT1 is linked to neoplasm.